Split History
How to Retire on 8%+ Dividends Paid Monthly »    CLRBW Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cellectar Biosciences is a biopharmaceutical company developing compounds for the treatment, diagnosis and imaging of cancer. Co.'s cancer-targeting technology permits selective delivery of a range of agents to cancer cells, including cancer stem cells. By attaching different agents to its phospholipid ether molecules as a cancer-targeting delivery platform, Co. develops product candidates with the potential to treat, diagnose and image a range of cancers. Co. is developing three product candidates: I-124-CLR1404, a cancer-targeting positron emission tomography imaging agent; I-131-CLR1404, a cancer-targeting molecular radiotherapeutic; and CLR1502, a non-radioactive optical imaging agent. According to our CLRBW split history records, CLRBW has had 1 split.
CLRBW split history picture
CLRBW (CLRBW) has 1 split in our CLRBW split history database. The split for CLRBW took place on March 07, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of CLRBW owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as CLRBW conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CLRBW split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CLRBW shares, starting with a $10,000 purchase of CLRBW, presented on a split-history-adjusted basis factoring in the complete CLRBW split history. CLRBW split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/13/2014
End date: 08/20/2019
Start price/share: $8.00
End price/share: $0.13
Dividends collected/share: $0.00
Total return: -98.38%
Average Annual Total Return: -57.86%
Starting investment: $10,000.00
Ending investment: $162.51
Years: 4.77
Date Ratio
03/07/20161 for 10
CLRBW is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CLSN Split History
CMD Split History
CMN Split History
CNC Split History
CNDO Split History
CNMD Split History
COO Split History
COV Split History
CRDC Split History
CRIS Split History

Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CLRBW Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.